1d
Zacks Investment Research on MSNWhy GSK (GSK) is a Top Momentum Stock for the Long-TermFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ...
GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.
Larson Financial Group LLC cut its holdings in GSK plc (NYSE:GSK – Free Report) by 52.7% during the fourth quarter, according ...
Atria Investments Inc cut its holdings in GSK plc (NYSE:GSK – Free Report) by 7.6% in the fourth quarter, according to the ...
GSK PLC closed 15.88% below its 52-week high of £18.24, which the company reached on May 16th.
NEW YORK, NY / ACCESS Newswire / March 12, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
GSK beats Wall Street expectations again, but stock price remains flat despite the success in R&D GSK's revenue was about $10.15 billion in the fourth quarter of 2024, down 0.49% year over year ...
Price Action: GSK stock is up 2.55% at $38.92 at the last check Tuesday. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Citadel has taken a short position worth 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, according to data from the Financial Conduct Authority, the FT report said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results